Bio-Techne Corp.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $269.0M | $264.0M |
| Biotechnology | — | — |
| Clinical Controls | — | — |
| Protein Platforms | — | — |
| Protein Sciences | — | — |
| Diagnostics and Genomics | — | — |
| Diagnostics and Spatial Biology | — | — |
| Other | — | — |
| Eliminations | — | — |
| Cost of Revenue | $54.9M | $55.9M |
| Gross Profit | $214.1M | $208.0M |
| Gross Margin | 79.6% | 78.8% |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $32.7M | $33.7M |
| Operating Income | $156.3M | $150.8M |
| Operating Margin | 58.1% | 57.1% |
| Interest Expense | — | — |
| Pretax Income | $156.4M | — |
| Income Tax Expense | $46.7M | $50.1M |
| Net Income | $109.8M | $105.2M |
| Net Margin | 40.8% | 39.9% |
| EPS (Basic) | $0.74 | $0.70 |
| EPS (Diluted) | $0.74 | $0.70 |
| Shares Outstanding (Basic) | 149.0M | 151.2M |
| Shares Outstanding (Diluted) | 149.4M | 151.6M |
| Dividends Per Share | $0.26 | $0.19 |